A synthetic peptide for use as a blocking control in assays to test for specificity of NARF antibody, Alternative Names: NARF control peptide, NARF antibody Blocking Peptide, Anti-NARF Blocking Peptide, Nuclear Prelamin A Recognition Factor Blocking Peptide, DKFZp434G0420 Blocking Peptide, FLJ10067 Blocking Peptide, IOP2 Blocking Peptide
Aufreinigung
The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
NARF
(Nuclear Prelamin A Recognition Factor (NARF))
Hintergrund
NARF binds to the prenylated prelamin A carboxyl-terminal tail domain. It may be a component of a prelamin A endoprotease complex. NARF is located in the nucleus, where it partially colocalizes with the nuclear lamina. It shares limited sequence similarity with iron-only bacterial hydrogenases.